Haemonetics Corp
HAE71.400USD
+0.920+1.31%
Market hours （ET）Quotes delayed by 15 min
3.34BMarket Cap
19.85P/E TTM
More Details of Haemonetics Corp Company
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Haemonetics Corp Info
Ticker SymbolHAE
Company nameHaemonetics Corp
IPO dateOct 17, 1979
CEOMr. Christopher A. Simon
Number of employees3023
Security typeOrdinary Share
Fiscal year-endOct 17
Address125 Summer Street
CityBOSTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02110
Phone17818487100
Websitehttps://www.haemonetics.com
Ticker SymbolHAE
IPO dateOct 17, 1979
CEOMr. Christopher A. Simon
Company Executives of Haemonetics Corp
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.24K
-4.28%
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
242.40M
75.42%
Europe
40.88M
12.72%
Asia
21.65M
6.74%
Japan
13.65M
4.25%
other
2.81M
0.87%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Nov 8
Updated: Sat, Nov 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.90%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
9.14%
Wellington Management Company, LLP
4.59%
State Street Investment Management (US)
4.02%
Other
60.05%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.90%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
9.14%
Wellington Management Company, LLP
4.59%
State Street Investment Management (US)
4.02%
Other
60.05%
Shareholder Types
Shareholders
Proportion
Investment Advisor
52.23%
Investment Advisor/Hedge Fund
49.81%
Research Firm
4.18%
Hedge Fund
3.57%
Bank and Trust
1.38%
Pension Fund
1.36%
Individual Investor
1.19%
Sovereign Wealth Fund
1.10%
Insurance Company
0.03%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
697
54.60M
116.65%
-5.18M
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.57M
11.56%
-96.61K
-1.71%
Jun 30, 2025
The Vanguard Group, Inc.
4.94M
10.26%
-145.60K
-2.86%
Jun 30, 2025
Neuberger Berman, LLC
4.28M
8.88%
-70.91K
-1.63%
Jun 30, 2025
Wellington Management Company, LLP
2.15M
4.46%
-478.59K
-18.23%
Jun 30, 2025
State Street Investment Management (US)
1.88M
3.91%
-34.03K
-1.77%
Jun 30, 2025
River Road Asset Management, LLC
1.66M
3.44%
+260.62K
+18.68%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.59M
3.31%
-600.70K
-27.36%
Jun 30, 2025
Royce Investment Partners
1.27M
2.64%
+109.76K
+9.45%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.24M
2.58%
+23.26K
+1.90%
Jun 30, 2025
Capital Research Global Investors
1.14M
2.36%
-438.28K
-27.79%
Jun 30, 2025
View more
Related ETFs
Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.49%
Harbor Human Capital Factor US Small Cap ETF
1.48%
Neuberger Berman Small-Mid Cap ETF
1.36%
First Trust Mid Cap US Equity Select ETF
0.68%
First Trust Small Cap US Equity Select ETF
0.64%
Lattice Hartford Multifactor Small Cap ETF
0.51%
WisdomTree US SmallCap Quality Growth Fund
0.29%
VictoryShares US Small Mid Cap Value Momentum ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.25%
First Trust Small Cap Growth AlphaDEX Fund
0.24%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.49%
Harbor Human Capital Factor US Small Cap ETF
Proportion1.48%
Neuberger Berman Small-Mid Cap ETF
Proportion1.36%
First Trust Mid Cap US Equity Select ETF
Proportion0.68%
First Trust Small Cap US Equity Select ETF
Proportion0.64%
Lattice Hartford Multifactor Small Cap ETF
Proportion0.51%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.29%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.26%
Royce Quant Small-Cap Quality Value ETF
Proportion0.25%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.24%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
